Comment
|
VEGFR2 inhibition abrogated Akt and ERK1/2 activation in VEGF treated cells irrespective of p38 MAPK inhibition.
|
Formal Description Interaction-ID: 5568
|
|
Drugbank entries
|
Show/Hide entries for
KDR
or
AKT1
|
Drugbank
DB00398
|
|
Drugbank
DB01268
|
|
Drugbank
DB04727
|
N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FUR ...
|
Drugbank
DB06938
|
4-[[2-[[4-chloro-3-(trifluoromethyl)phen ...
|
Drugbank
DB07183
|
N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmeth ...
|
Drugbank
DB07274
|
N-cyclopropyl-6-[(6,7-dimethoxyquinolin- ...
|
Drugbank
DB07326
|
6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluo ...
|
Drugbank
DB07333
|
N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({ ...
|
Drugbank
DB07334
|
N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5- ...
|
Drugbank
DB07514
|
3-(2-aminoquinazolin-6-yl)-1-(3,3-dimeth ...
|
Drugbank
DB07528
|
3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3 ...
|
Drugbank
DB07537
|
N'-(6-aminopyridin-3-yl)-N-(2-cyclopenty ...
|
Drugbank
DB08042
|
N~4~-methyl-N~4~-(3-methyl-1H-indazol-6- ...
|
Drugbank
DB08519
|
N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3, ...
|
Drugbank
DB04727
|
N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FUR ...
|
Drugbank
DB00171
|
|
Drugbank
DB01169
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
Drugbank
DB07584
|
N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phe ...
|
Drugbank
DB07585
|
5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4 ...
|
Drugbank
DB00171
|
|
Drugbank
DB01863
|
Inositol 1,3,4,5-Tetrakisphosphate
|
|
|